Trubion Pharmaceutical completed its IPO
On Oct. 18, 2006, Trubion Pharmaceutical completed its IPO of 4,000,000 shares of common stock at $13.00 per…
Biotechnology | Diagnostics | Disease | Genomics | Life Science News | NIH | Oncology | Therapeutics
NIH announced two integral components of the Cancer Genome Atlas Pilot Project
On Oct. 16, 2006, the Cancer Genome Atlas program, created by National Cancer Institute and the National Human…
National Cancer Institute scientists identified novel protein that ties disruption of critical cellular pathway to Birt-Hogg-Dub syndrome
On Oct 2, 2006, National Cancer Institute researchers have linked specific genetic mutations to defects in cells that…
The Allen Institute for Brain Science Completed the Brain Atlas
On Sept. 26, 2006, the Allen Institute for Brain Science announced the completion of the groundbreaking Allen Brain…
Integrated DNA Technologies acquired Belgian manufacturer and established European operating base in Leuven, Belgium
On Sept. 18, 2006, Integrated DNA Technologies (IDT) announced the acquisition of RNA-TEC, based in Leuven, Belgium. The…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Therapeutics
The OMRF celebrated it’s 60th anniversary
On Sept. 15, 2006, the Oklahoma Medical Research Foundation (OMRF) celebrated it’s 60th anniversary. More than 600 people…
National Cancer Institute researchers developed a new model for estimating the 5-year risk of melanoma
On Sept. 1, 2006, National Cancer Institute (NCI) researchers developed a new model for estimating the 5-year risk…
National Cancer Institute researchers discovered unique pattern of gene activity that predict liver cancer spread
On Aug. 14, 2006, National Cancer Institute (NCI) researchers announced they had found a unique pattern of activity…
Alaska Airlines awarded E. Donnall Thomas Medal of Achievement Medal
On Jul. 18, 20006, the Fred Hutchinson Business Alliance announced that the E. Donnall Thomas Medal of Achievement…
Biotechnology | Diagnostics | Disease | Life Science News | Oncology | Therapeutics | Women's Health
Personalized treatment trial for breast cancer was launched
On May 23, 2006, the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, was launched to examine…
Osteoporosis drug shown to be as effective as Tamoxifen in preventing invasive breast cancer
On Apr. 17, 2006, the National Cancer Institute (NCI) announced initial results of the Study of Tamoxifen and…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Therapeutics
Fred Hutchinson Cancer Research Center Joined Livestrong™ Survivorship Center of Excellence Network
On Mar. 20, 2006, the Fred Hutchinson Cancer Research Center announced that it had joined the Lance Armstrong…
Acorda Therapeutics announced its its initial public offering
On Feb. 10, 2006, Acorda Therapeutics announced an initial public offering of 5,500,000 shares of common stock at…
Agriculture | Disease | Life Science News | USDA | Vaccine
USDA granted Dow AgroSciences the first regulatory approval for a plant-made vaccine
In 2006, the U.S. Department of Agriculture (USDA) granted Dow AgroSciences the first regulatory approval for a plant-made…
Biotechnology | Diagnostics | Disease | Life Science News | Oncology | Radiology | Therapeutics | Women's Health
NCI launched TAILORx trial to determine whether gene expression patterns in early-stage breast cancer can distinguish women at high risk of recurrence
In 2006, the National Cancer Institute (NCI) launched the TAILORx trial to determine whether gene expression patterns in…
The prevalence of U.S. adult smoking declined to 20.8 percent in 2006
In 2006, an estimated 20.8% (45.3 million) of U.S. adults were current cigarette smokers; of these, 80.1% (36.3…
The Science Foundation Arizona was founded
In 2006, the Science Foundation Arizona (SFAz), a 501(C)(3) non profit, was initiated by the three statewide CEO…
Biotechnology | Diagnostics | Disease | Life Science News | Nanotechnology | Non-Profit Research | Therapeutics
Yale New Haven Hospital breaks ground on $838 million, 505,000 square foot Neurosciences Center
On Aug. 31, 2022, Yale New Haven Hospital (YNHH) broke ground on the $838 million, 505,000 square foot…
Biotechnology | Diagnostics | Disease | Life Science News | Medicine | Non-Profit Research | Therapeutics
OHSU’s Peter O Kohler Pavilion opened as state-of-the-art patient care facility on Marquam Hill
In 2006, The OHSU Peter O. Kohler Pavilion opened as state-of-the-art patient care facility on Marquam Hill in…
Biotechnology | Diagnostics | Disease | Life Science News | Medicine | NIH | Non-Profit Research | Therapeutics
Robert C. Byrd Biotechnology Science Center opened
In 2006, Robert C. Byrd Biotechnology Science Center officially opened. The center was constructed with a grant of…
The Northwest Lions Foundation for Sight & Hearing was renamed as SightLife to better reflect its national and international role
In 2006, the Board of Trustees of the Northwest Lions Foundation for Sight & Hearing renamed Northwest Lions…
NCI and NHGRI launched effort to accelerate understanding molecular basis of cancer with genome analysis
On Dec. 13, 2005, the National Cancer Institute (NCI) and the National Human Genome Research Institute launched a…
Biotechnology | Diagnostics | Disease | Life Science News | Oncology | Therapeutics | Women's Health
Studies validated a new test can predict risk of breast cancer recurrence in a sizable group of patients
On Dec. 7, 2005, results from several studies presented at the San Antonio Breast Cancer Symposium validated that…
Biotechnology | Diagnostics | Disease | Life Science News | NIH | Non-Profit Research | Oncology | Therapeutics
Annual Report to the Nation on the Status of Cancer showed cancer death rates dropped from 1993-2002
On Oct. 5, 2005, the National Cancer Institute’s Annual Report to the Nation on the Status of Cancer,…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
Siteman Cancer Center opened a new center at Barnes-Jewish St Peters Hospital
On Sept. 22, 2005, the Siteman Cancer Center opened a new center at Barnes-Jewish St. Peters Hospital. The…
Preliminary results from clinical trial of digital vs. film mammography showed no difference in breast cancer detection
On Sept. 16, 2005, preliminary results from a large, clinical trial of digital vs. film mammography showed no…
Biotechnology | Disease | NIH | Therapeutics
The Patient Navigator Outreach and Chronic Disease Prevention Act amended the Public Health Service Act
On Jun. 29, 2005, the Patient Navigator Outreach and Chronic Disease Prevention Act of 2005 (P.L. 109-18) amended…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
Karmanos Cancer Institute acquired clinical facilities from the Detroit Medical Center
On May 1, 2005, The Wayne State University Karmanos Cancer Institute announced it had acquired its clinical facilities…
Biotechnology | Diagnostics | Disease | Life Science News | Oncology | Therapeutics | Women's Health
NCI-sponsored clinical trials showed patients with early-stage, HER2-positive, invasive breast cancer experienced decrease in risk of cancer recurrence
On Apr. 27, 2005, results from two large National Cancer Institute sponsored randomized clinical trials showed that patients…
NCI trial reported targeted agent trastuzumab and standard chemo cut risk of HER-2-positive breast cancer
On Apr. 25, 2005, the combination of the targeted agent trastuzumab (Herceptin) and standard chemotherapy cuts the risk…